Lumenis launches lasers & delivery devices

Article

Four new ophthalmic lasers and delivery devices have been unveiled by Lumenis at the meeting of the American Academy of Ophthalmology.

Four new ophthalmic lasers and delivery devices have been unveiled by Lumenis at the meeting of the American Academy of Ophthalmology.

Two lasers were launched: the Selecta Trio, a single platform laser offering retina, cataract and glaucoma therapies, which features enhanced optics and an advanced laser cavity; and the Selecta Duet, an anterior segment laser offering both YAG and selective laser trabeculoplasty (SLT) technology.

Lumenis also launched two delivery devices. The Novus Spectra Dual-Port, a 2.5 W photocoagulator that utilizes diode-pumped solid-state (DPSS) technology, features an active resonator temperature control and is designed to be suitable for both the operating room and in an outpatient setting. The LumeProbe Endo Photocoagulation Laser Probes, designed for treating vitreoretinal indications in the operating room, constitute the final new Lumenis product offering.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.